Nanoformulations of natural products for management of metabolic syndrome

Código QR

Nanoformulations of natural products for management of metabolic syndrome

Yasamin Davatgaran Taghipour,1–3 Marziyeh Hajialyani,4 Rozita Naseri,5 Mahvash Hesari,6 Pantea Mohammadi,6 Azzurra Stefanucci,7 Adriano Mollica,7 Mohammad Hosein Farzaei,4,6 Mohammad Abdollahi81Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz Unive...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A, Mollica A, Farzaei MH, Abdollahi M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	nanoformulations natural products metabolic syndrome diabetes Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/308c5fc0c1ff478289d9cce5ccf40e25
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
por: Davatgaran-Taghipour Y, et al.
Publicado: (2017)

Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases
por: Hesari M, et al.
Publicado: (2021)

Diabetology & metabolic syndrome

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi Q, et al.
Publicado: (2017)

Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Ramsha Aamir, et al.
Publicado: (2021)

Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation
por: Rani R, et al.
Publicado: (2019)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota K, et al.
Publicado: (2017)

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publicado: (2009)

A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
por: Dongju Zhao, et al.
Publicado: (2021)

Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes
por: Guo X, et al.
Publicado: (2021)

Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome
por: Walden P, et al.
Publicado: (2016)

Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten
por: Husain NE, et al.
Publicado: (2017)

Affective disorders in patients with metabolic syndrome
por: N. S. Alekseeva, et al.
Publicado: (2014)

Metabolic syndrome: Epidemiology, diagnostic criteria, racial characteristics
por: N. I. Vilson, et al.
Publicado: (2021)

Effect of duration of diabetes mellitus on the prevalence of diabetic retinopathy in patients with type 2 diabetes and metabolic syndrome
por: Rena kyzy Guseynova, et al.
Publicado: (2010)

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
por: Suman RK, et al.
Publicado: (2016)

Examination of the Relationship Between Metabolic Syndrome and Obstructive Sleep Apnea in Iranian Patients with Type 2 Diabetes: A Case–Control Study
por: Sharifpour P, et al.
Publicado: (2020)

INFLUENCE OF COMPONENTS OF METABOLIC SYNDROME ON THE PATIENTS’ LIFE QUALITY
por: N. S. Alekseyeva
Publicado: (2014)

The Magnitude and Directions of the Associations between Early Life Factors and Metabolic Syndrome Differ across Geographical Locations among Migrant and Non-Migrant Ghanaians—The RODAM Study
por: Thijs G. W. van der Heijden, et al.
Publicado: (2021)

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
por: Davies MJ, et al.
Publicado: (2017)

COSMIC project: consensus on the objectives of the metabolic syndrome in clinic
por: Pedro-Botet J, et al.
Publicado: (2018)

3rd International Congress of on prediabetes and metabolic syndrome, 1-4 April 2009, Nice
por: Elena Vladimirovna Pekareva, et al.
Publicado: (2009)

Self-Assembling Peptides as an Emerging Platform for the Treatment of Metabolic Syndrome
por: Castillo-Díaz LA, et al.
Publicado: (2020)

Nut Consumption Is Associated with Lower Risk of Metabolic Syndrome and Its Components in Type 1 Diabetes
por: Aila J. Ahola, et al.
Publicado: (2021)

Metabolic syndrome: some results and prospects for solving the problem
por: X. Chu, et al.
Publicado: (2016)

Relationship between body-roundness index and metabolic syndrome in type 2 diabetes
por: Liu B, et al.
Publicado: (2019)

Association of Metabolic Syndrome with Sensorineural Hearing Loss
por: Hwa-Sung Rim, et al.
Publicado: (2021)

The 7th International DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy March 13th?16th, 2013, Florence, Italy
por: Alena Viktorovna Tiselko
Publicado: (2013)

PROTEINS OF THE ERYTHROCYTE MEMBRANE AND METABOLIC SYNDROME
por: A. S. Sergeyeva, et al.
Publicado: (2015)

Association between serum adiponectin levels with gestational diabetes mellitus and postpartum metabolic syndrome:A case control study
por: Atarod Zoleikha, et al.
Publicado: (2020)

Association between hair cortisol concentration and metabolic syndrome
por: Mazgelytė Eglė, et al.
Publicado: (2021)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study
por: Che-Wei Chang, et al.
Publicado: (2021)

Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs
por: AbouAitah K, et al.
Publicado: (2020)

A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction
por: Bello-Chavolla OY, et al.
Publicado: (2021)

Clinical utility of metabolic syndrome severity scores: considerations for practitioners
por: DeBoer MD, et al.
Publicado: (2017)

The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis
por: Tingting Che, et al.
Publicado: (2021)

Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer
por: Gupta P, et al.
Publicado: (2018)

Intracellular metabolism of neutrophils and risk for development of type 2 diabetes mellitus in patients with metabolic syndrome
por: Andrey Evgen'evich Kratnov, et al.
Publicado: (2012)

The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome
por: Desai P, et al.
Publicado: (2020)